B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients

Front Immunol. 2023 Nov 10:14:1230306. doi: 10.3389/fimmu.2023.1230306. eCollection 2023.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest solid tumors and is resistant to immunotherapy. B cells play an essential role in PDAC progression and immune responses, both locally and systemically. Moreover, increasing evidence suggests that microbial compositions inside the tumor, as well as in the oral cavity and the gut, are important factors in shaping the PDAC immune landscape. However, the gut-associated lymphoid tissue (GALT) has not previously been explored in PDAC patients. In this study, we analyzed healthy vermiform appendix (VA) from 20 patients with PDAC and 32 patients with colon diseases by gene expression immune profiling, flow cytometry analysis, and microbiome sequencing. We show that the VA GALT of PDAC patients exhibits markers of increased inflammation and cytotoxic cell activity. In contrast, B cell function is decreased in PDAC VA GALT based on gene expression profiling; B cells express significantly fewer MHC class II surface receptors, whereas plasma cells express the immune checkpoint molecule HLA-G. Additionally, the vermiform appendix microbiome of PDAC patients is enriched with Klebsiella pneumoniae, Bifidobacterium animalis, and Adlercreutzia equolifaciens, while certain commensals are depleted. Our findings may suggest impaired B cell function within the GALT of PDAC patients, which could potentially be linked to microbial dysbiosis. Additional investigations are imperative to validate our observations and explore these potential targets of future therapies.

Keywords: HLA-DR; HLA-G; colon cancer; gut associated lymphoid tissue; gut microbiome; mucosal B cells; pancreatic cancer; vermiform appendix.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Appendix* / microbiology
  • Appendix* / pathology
  • Carcinoma, Pancreatic Ductal* / pathology
  • Dysbiosis
  • HLA-G Antigens
  • Humans
  • Pancreatic Neoplasms* / pathology

Substances

  • HLA-G Antigens

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by the Survival with Pancreatic Cancer Foundation (Support Casper).